Asia Pacific Biopharmaceutical Tubing Market

Market Introduction

Biopharmaceutical tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps. These offer exceptional thermal, mechanical, and chemical properties used in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment.

Market Overview and Dynamics

The Asia Pacific biopharmaceutical tubing market is expected to reach US$ 903.19 million by 2028 from US$ 487.50 million in 2021; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028. The growth of the market is attributed to key factors such as increasing elderly population in world and proliferation of healthcare sector in developing economies. However, stringent regulatory framework by government for biopharmaceutical applications is expected to restrict the market growth during the forecast period.

Popularity of minimally invasive surgical procedures has increased in the recent years owing to the benefits such as tiny incisions, faster recovery of patients, and less discomfort caused to the patients. The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted the demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Further, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing. The healthcare sectors in Asia Pacific countries as well as other developing economies is projected to expand rapidly in the near future, and the projected growth can be ascribed to changes in customer demand, increase in awareness about healthcare services, and continuity of aging population. Thus, growing prevalence of chronic diseases is compelling people to seek medical assistance, which, in turn is increasing the demand for catheters and biopharmaceutical tubing in the healthcare sector. Further, greater government spending on healthcare facilities and increased consumer purchasing power are also likely to contribute to the growth of the healthcare sector, as well as the biopharmaceutical tubing market. 

Countries in Asia Pacific are facing challenges due to increasing incidences of COVID-19. Increasing usage in a wide range of applications such as drug delivery, catheter & cannulas, and bulk disposable tubing has increased the demand for the biopharmaceutical tubing market. However, due to the impact of pandemic, the medical device industry has experienced both ups and downs and witnessed increased demand for critical pieces of equipment such as ventilators and respiratory devices. While the COVID-19 has caused unprecedented disruption, it has also created opportunities for the region's pharmaceutical and medical device sectors. Many companies have also extended their operations in the region to overcome supply chain hindrance. Hence, COVID-19 pandemic has a positive influence on Asia Pacific biopharmaceutical tubing market growth.

Key Market Segments

Based on type, the Asia Pacific biopharmaceutical tubing market is segmented into plastic, metal, and silicone. The silicone segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

Based on application, the Asia Pacific biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. The pharmaceutical segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Asia Pacific biopharmaceutical tubing market are the Organization for Economic Co-operation and Development (OECD), Indian Brand Equity Fund (IBEF) and Centers for Disease Control and Prevention (CDC).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Asia Pacific biopharmaceutical tubing market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Asia Pacific biopharmaceutical tubing market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific biopharmaceutical tubing market.

ASIA PACIFIC BIOPHARMACEUTICAL TUBING MARKET SEGMENTATION

By Type

• Silicone
• Plastic
• Metal

By Application

• Pharmaceutical
• Medical Devices
• Research and Development
• Others

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Company Profiles

• W. L. Gore and Associates, Inc.
• Saint-Gobain Sekurit
• Freudenberg Group
• RAUMEDIC AG
• TEKNI-PLEX
• NewAge Industries, Inc
• Optinova
• Zeus Industrial Products, Inc.
• NORDSON CORPORATION
• DuPont de Nemours, Inc.

Asia Pacific Biopharmaceutical Tubing Market Strategic Insights

Asia Pacific Biopharmaceutical Tubing Market Segmentation Analysis

Asia Pacific Biopharmaceutical Tubing Market Report Highlights

Asia Pacific Biopharmaceutical Tubing Report Scope

Asia Pacific Biopharmaceutical Tubing Market Country and Regional Insights